Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Sanofi Says to Fight Class Action Bid
Link ID 2172
Title Sanofi Says to Fight Class Action Bid
Url http://www.medscape.com/viewarticle/568280?src=rss
Description Drugmaker Sanofi-Aventis, the target of a lawsuit seeking class-action status filed on behalf of shareholders, on Friday vowed to fight allegations it hid the side-effects of its anti-obesity drug Acomplia. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Jan 8, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Quality of Informed Consent for Invasive Procedures
  The quality of obtaining informed consent is inconsistent. What are the qualitative aspects of this process for patients undergoing surgery/other invasive procedures? How can quality be standardized?
International Journal for Quality in Health Care
Category:   Articles > Business of Medicine


2. Brown Backs "Presumed Consent" Organ Donor Policy
  British Prime Minister Gordon Brown gave his backing on Sunday to hospitals wanting to adopt a system of "presumed consent" for the removal of organs from dead patients. Reuters Health Information
Category:   Articles > Business of Medicine


3. WellCare Shares Fall After Q2 Filing Delay
  Shares of WellCare Health Plans Inc fell as much as 11 percent on Wednesday, a day after the company said it would delay filing results for the quarter ended June, as it sorts out details related to a government probe and earnings restatement. Reuters Health Information
Category:   Articles > Business of Medicine


4. U.S. Diabetes Costs Top $174 Billion
  Study shows that diabetes costs in the United States have risen nearly one-third since 2002. WebMD Health News
Category:   Articles > Business of Medicine


5. FDA Approves Focalin XR for ADHD
  The 30-minute onset of action for Focalin XR is thought to benefit young patients with attention-deficit/hyperactivity disorder because it helps control symptoms while they are preparing for school and attending classes. Medscape Medical News
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS